16:43 IST
BSE
Acquisition
Cipla Acquisition
Cipla is notifying shareholders and creditors about a Scheme of Amalgamation with Inzpera Healthsciences, providing them an opportunity to submit representations to the NCLT.
Cipla Ltd
- Share price
- ₹1,327.20
- Market cap
- ₹1,07,221 Cr
- Revenue (annual)
- ₹28,163 Cr
- Net profit (annual)
- ₹3,879 Cr
- P/E (TTM)
- 31.8×Sector 47.3×
- Promoter holding
- 29.21%+0.00% QoQ
- FII holding
- 20.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 6Employee Stock Options 6Business Update 5Management Change 4Financial Results 4Regulatory Approval 3Earnings Call 3Results Update 2Annual Report 2Annual General Meeting 2Acquisition 2Partnership 1Merger & Restructuring 1Dividend 1Board Meeting Outcome 1Board Meeting Date 1
Time
2 announcements with these filters
17:01 IST
NSE
Acquisition
Cipla Acquisition
Cipla Ltd announced that the NCLT has allowed the scheme application for the amalgamation of its wholly-owned subsidiary, Inzpera Healthsciences Ltd, into Cipla Ltd.